FDA recall D-0910-2023

Product

allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-count cartons (NDC 11673-617-39), c)70-count cartons (NDC 11673-617-01), and d)150-count cartons (11673-617-47), Distributed by: Target Corporation, Minneapolis, MN 55403.

Reason for recall

Failed Impurities/Degradation Specifications

Distribution

Nationwide within the USA

Key facts

Status

Terminated

Initiation date

2023-02-09

Report date

2023-07-19

Termination date

2023-09-11

Voluntary/Mandated

Voluntary: Firm initiated

Location

Allegan, MI, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0910-2023